Pages that link to "Q70449262"

The following pages link to Bioavailability, pharmacokinetics and effects of glipizide in type 2 diabetics (Q70449262):

Displaying 19 items.

• Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance (Q36350528) (← links)
• Impact of therapeutic advances on hypoglycaemia in type 2 diabetes (Q37071750) (← links)
• The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans (Q37742575) (← links)
• Effect of Diabetes Mellitus on Pharmacokinetic and Pharmacodynamic Properties of Drugs (Q38016232) (← links)
• Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. (Q38618657) (← links)
• Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update (Q38631248) (← links)
• The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs (Q39662366) (← links)
• Clinical pharmacokinetics and endocrine disorders. Therapeutic implications (Q39693651) (← links)
• Is There a Concentration-Effect Relationship for Sulphonylureas? (Q41734941) (← links)
• Differential effects of sodium bicarbonate and aluminium hydroxide on the absorption and activity of glipizide (Q41980567) (← links)
• Lack of primary effect of sulphonylurea (glipizide) on plasma lipoproteins and insulin action in former type 2 diabetics with attenuated insulin secretion (Q44629598) (← links)
• Targeting Postprandial Hyperglycemia: A Comparative Study of Insulinotropic Agents in Type 2 Diabetes (Q44645531) (← links)
• Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers (Q46970225) (← links)
• The influence of glipizide on early insulin release and glucose disposal before and after dietary regulation in diabetic patients with different degrees of hyperglycaemia (Q51627421) (← links)
• Therapeutic equivalence of once- and thrice-daily glipizide (Q51635437) (← links)
• Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics (Q51639833) (← links)
• Bioavailability prediction based on molecular structure for a diverse series of drugs (Q52003016) (← links)
• Prediction of drug bioavailability based on molecular structure (Q62566944) (← links)
• Hyperglycaemia and absorption of sulphonylurea drugs (Q69371278) (← links)